U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 21 to 40 of 64

Tests names and labsConditionsGenes, analytes, and microbesMethods

Genetic study of pharmacogenetics

HeartGenetics, Genetics and Biotechnology, SA
Portugal
126
  • T Targeted variant analysis

CYP3A5 Genotype

Mayo Clinic Laboratories Mayo Clinic
United States
20
  • T Targeted variant analysis

Psychotropic Pharmacogenomics Gene Panel

Mayo Clinic Laboratories Mayo Clinic
United States
121
  • T Targeted variant analysis

Focused Pharmacogenomics Panel

Mayo Clinic Laboratories Mayo Clinic
United States
122
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Pharmacogenetic Panel

Sanford Medical Genetics Laboratory Sanfordhealth
United States
514
  • T Targeted variant analysis

Tempus xT

Tempus AI - CHI
United States
2647
  • I Microsatellite instability testing (MSI)
  • C Sequence analysis of the entire coding region

Rxight Pharmacogenetics Program

MD Labs
United States
628
  • T Targeted variant analysis

ONCOMAMApgx

Eugenomic S.L.
Spain
2613
  • T Targeted variant analysis

Pharmacogenomics Profile + HLA

AccessDx Lab LLC
United States
7137
  • D Deletion/duplication analysis
  • T Targeted variant analysis

CARDIOpgx

Eugenomic S.L.
Spain
116
  • T Targeted variant analysis

PSICOpgx

Eugenomic S.L.
Spain
779
  • T Targeted variant analysis

GLOBALpgx

Eugenomic S.L.
Spain
14521
  • T Targeted variant analysis

PGx-NP (Neuro-Psychiatry)

SPMED CO., LTD Step forward Personalized Medicine
South Korea
5126
  • T Targeted variant analysis

PGx-Premium (Preemptive PGx test)

SPMED CO., LTD Step forward Personalized Medicine
South Korea
6627
  • T Targeted variant analysis

PGx-Standard (Preemptive PGx test)

SPMED CO., LTD Step forward Personalized Medicine
South Korea
3110
  • T Targeted variant analysis

Pharmacogenomics SNaP-Shot

Ariel Precision Medicine
United States
126
  • T Targeted variant analysis

Polypharmacy Comprehensive Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
3324
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Hypertension, salt-sensitive essential, susceptibility to, 145500, Multifactorial (CYP3A5 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Hypertension, salt-sensitive essential, susceptibility to, 145500, Multifactorial (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

NeuroIDgenetix

AltheaDx/Castle Biosciences
United States
211
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Results: 21 to 40 of 64

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.